ES2174291T3 - Preparacion topica para introducir medicamentos peptidicos en organismos vivos. - Google Patents

Preparacion topica para introducir medicamentos peptidicos en organismos vivos.

Info

Publication number
ES2174291T3
ES2174291T3 ES97943081T ES97943081T ES2174291T3 ES 2174291 T3 ES2174291 T3 ES 2174291T3 ES 97943081 T ES97943081 T ES 97943081T ES 97943081 T ES97943081 T ES 97943081T ES 2174291 T3 ES2174291 T3 ES 2174291T3
Authority
ES
Spain
Prior art keywords
peptidic
introduce
living organisms
medicines
topical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97943081T
Other languages
English (en)
Inventor
Zoltan Dardai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diabetic Trust AG
Original Assignee
Diabetic Trust AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabetic Trust AG filed Critical Diabetic Trust AG
Application granted granted Critical
Publication of ES2174291T3 publication Critical patent/ES2174291T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PREPARADOS FARMACEUTICOS CON APLICACIONES LOCALES QUE PERMITEN INTRODUCIR MEDICAMENTOS PEPTIDICOS EN ORGANISMOS VIVOS POR RESORCION TRANSDERMICA. ESTOS PREPARADOS COMPRENDEN (I) UN MEDICAMENTO PEPTIDICO, (II) UN EXTRACTO CAPSAICINO, HISTAMINA Y/O CANTARIS, Y (III) UN AGENTE DE EPITELIZACION. LOS PREPARADOS MEZCLADOS CON EXCIPIENTES Y/O DILUYENTES APLICABLES DE MANERA CLASICA EN LOS PREPARADOS FARMACEUTICOS LOCALES SON APLICADOS FACULTATIVAMENTE EN UN SOPORTE CAPAZ DE ADHERIRSE A LA PIEL.
ES97943081T 1996-12-03 1997-09-08 Preparacion topica para introducir medicamentos peptidicos en organismos vivos. Expired - Lifetime ES2174291T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9603327A HU223205B1 (hu) 1996-12-03 1996-12-03 Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére

Publications (1)

Publication Number Publication Date
ES2174291T3 true ES2174291T3 (es) 2002-11-01

Family

ID=89994502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97943081T Expired - Lifetime ES2174291T3 (es) 1996-12-03 1997-09-08 Preparacion topica para introducir medicamentos peptidicos en organismos vivos.

Country Status (24)

Country Link
US (1) US6399566B1 (es)
EP (1) EP0942743B1 (es)
JP (1) JP2001505222A (es)
KR (1) KR100466757B1 (es)
CN (1) CN1239436A (es)
AP (1) AP1065A (es)
AT (1) ATE213954T1 (es)
AU (1) AU744380B2 (es)
BR (1) BR9714945A (es)
CA (1) CA2272604A1 (es)
CZ (1) CZ289788B6 (es)
DE (1) DE69710918T2 (es)
DK (1) DK0942743T3 (es)
EA (1) EA002023B1 (es)
ES (1) ES2174291T3 (es)
HU (1) HU223205B1 (es)
IL (1) IL129915A0 (es)
IS (1) IS5052A (es)
NO (1) NO992668L (es)
NZ (1) NZ336045A (es)
OA (1) OA11180A (es)
SK (1) SK284306B6 (es)
TR (1) TR199901232T2 (es)
WO (1) WO1998024470A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225734B1 (en) * 1999-07-28 2007-07-30 Zoltan Dardai Multilayer plaster for introducing peptidaceous pharmacons in living organisms and process for producing thereof
AU6751000A (en) * 1999-07-30 2001-02-19 Maxim Pharmaceuticals, Inc. Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
JP2006518380A (ja) 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
KR101457263B1 (ko) * 2012-02-03 2014-11-07 단국대학교 산학협력단 파스의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3009143A1 (de) 1980-03-10 1981-10-01 Hans Dr Bauersfeld Arzneimittelzubereitung und deren verwendung
JPS5879913A (ja) * 1981-11-09 1983-05-13 Taizo Ayukawa ヘアトニツク組成物
AU651342B2 (en) * 1990-04-05 1994-07-21 Nurture, Inc. Film-forming proteinaceous emulsion
CH687053A5 (fr) * 1993-10-05 1996-09-13 Crina Additifs pour l'alimentation animale et procédé pour leur préparation.
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
AUPN089295A0 (en) 1995-02-02 1995-03-02 International Diabetes Institute Treatment of diabetic neuropathy

Also Published As

Publication number Publication date
SK68799A3 (en) 2000-02-14
HUP9603327A2 (hu) 1998-10-28
EA002023B1 (ru) 2001-12-24
DE69710918T2 (de) 2002-10-24
JP2001505222A (ja) 2001-04-17
CZ289788B6 (cs) 2002-04-17
HU9603327D0 (en) 1997-01-28
AP9901554A0 (en) 1999-06-30
IL129915A0 (en) 2000-02-29
NZ336045A (en) 2000-10-27
EP0942743B1 (en) 2002-03-06
KR20000057371A (ko) 2000-09-15
DK0942743T3 (da) 2002-06-10
SK284306B6 (sk) 2005-01-03
KR100466757B1 (ko) 2005-01-24
HUP9603327A3 (en) 1998-11-30
EP0942743A1 (en) 1999-09-22
NO992668D0 (no) 1999-06-02
WO1998024470A1 (en) 1998-06-11
AU744380B2 (en) 2002-02-21
BR9714945A (pt) 2002-02-13
HU223205B1 (hu) 2004-03-29
US6399566B1 (en) 2002-06-04
AP1065A (en) 2002-04-30
NO992668L (no) 1999-06-02
ATE213954T1 (de) 2002-03-15
TR199901232T2 (xx) 1999-08-23
CA2272604A1 (en) 1998-06-11
CN1239436A (zh) 1999-12-22
IS5052A (is) 1999-05-18
OA11180A (en) 2003-05-12
AU4468897A (en) 1998-06-29
CZ192099A3 (cs) 1999-09-15
DE69710918D1 (de) 2002-04-11
EA199900438A1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
MX21452A (es) Preparaciones farmaceuticas que se administran en forma topica.
ES2159564T3 (es) Preparados farmaceuticos para principios activos dificilmente solubles.
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
HU230005B1 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DE69637961D1 (de) Verabreichung von biologisch aktiven polypeptiden
BG103552A (bg) Терапевтични средства
DK1032363T3 (da) Leveringssystem med konjugeret linolsyre i kosmetiske præparater
ES2134355T3 (es) Copolimeros elastomeros termoplasticos y composiciones para el cuidado del cabello y de la piel que los contienen.
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
DE69828817D1 (de) Pharmazeutische aerosolzusammensetzungen
AR007582A1 (es) Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel.
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
FR2677248B1 (fr) Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de brunelle.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
ES2145114T3 (es) Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias.
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 942743

Country of ref document: ES